Blue Calypso 10-Q 8 Nov 13 2013 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Sep. 30, 2013	Nov. 08, 2013
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'BLUE CALYPSO, INC.	'
Document Type	'10-Q	'
Current Fiscal Year End Date	'--12-31	'
Entity Common Stock, Shares Outstanding	'	167,232,688
Amendment Flag	'false	'
Entity Central Index Key	'0001399587	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Well-known Seasoned Issuer	'No	'
Document Period End Date	30-Sep-13	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2013	Dec. 31, 2012
ASSETS	'	'
Cash and cash equivalents	$720,085	$218,798
Accounts receivable, net	16,600	43,868
Prepaid expenses	108,025	3,052
Total current assets	844,710	265,718
Property and equipment, net	12,092	16,628
Capitalized software development costs, net	1,025,612	923,449
Deferred financing costs, net of amortization of $46,579 as of September 30, 2013	187,921	'
Total assets	2,070,335	1,205,795
LIABILITIES AND STOCKHOLDERS' DEFICIENCY	'	'
Accounts payable	167,096	84,947
Accrued expenses	79,878	209,575
Deferred revenue	'	10,000
Convertible notes payable	'	465,000
Convertible notes payable-affiliate, net of discount of $244,705 as of December 31, 2012	'	278,186
Conversion option liability	'	109,802
Warrant liabilities	6,343	10,854,204
Total current liabilities	253,317	12,011,714
Convertible notes payable, net of discount of $334,320 and $213,500 as of September 30, 2013 and December 31, 2012, respectively	2,665,680	236,500
Total liabilities	2,918,997	12,248,214
Stockholders' deficiency:	'	'
Preferred stock, $0.0001 par value, 5,000,000 shares authorized; Series A convertible preferred stock, $0.0001 par value; 1,700,000 shares designated; 750,068 and 1,700,000 shares issued and outstanding as of September 30, 2013 and December 31, 2012, respectively	75	170
Common stock, $0.0001 par value; 680,000,000 shares authorized, 155,686,534 and 125,135,113 shares issued and outstanding as of September 30, 2013 and December 31, 2012, respectively	15,569	12,514
Additional paid in capital	19,992,113	6,552,878
Deficit accumulated during development stage	-20,856,419	-17,607,981
Total stockholders' deficiency	-848,662	-11,042,419
Total liabilities and stockholders' deficiency	2,070,335	1,205,795
Series A Preferred Stock [Member]	'	'
Stockholders' deficiency:	'	'
Preferred stock, $0.0001 par value, 5,000,000 shares authorized; Series A convertible preferred stock, $0.0001 par value; 1,700,000 shares designated; 750,068 and 1,700,000 shares issued and outstanding as of September 30, 2013 and December 31, 2012, respectively	$75	$170

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Deferred financing costs, net of amortization (in Dollars)	$46,579	'
Convertible notes payable, Discount (in Dollars)	'	225,000
Common stock, par value (in Dollars per share)	$0.00	$0.00
Common stock, Authorized shares	680,000,000	680,000,000
Common stock, issued shares	155,686,534	125,135,113
Common stock, outstanding shares	155,686,534	125,135,113
Convertible Note Paybe Affiliate [Member]	'	'
Convertible notes payable, Discount (in Dollars)	'	244,705
Convertible Notes Payble [Member]	'	'
Convertible notes payable, Discount (in Dollars)	$334,320	$213,500
Series A Preferred Stock [Member]	'	'
Preferred stock, par value (in Dollars per share)	$0.00	$0.00
Preferred stock, Authorized shares	5,000,000	5,000,000
Series A Convertible Preferred stock, issued shares	750,068	1,700,000
Series A Convertible Preferred stock, outstanding shares	750,068	1,700,000
Series A Convertible Preferred Stock, designated Shares	1,700,000	1,700,000

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)	3 Months Ended		9 Months Ended		49 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
REVENUE	$235,483	$9,547	$250,483	$10,307	$376,694
Cost of revenue	153,989	8,717	160,815	154,233	427,348
Gross profit (loss)	81,494	830	89,668	-143,926	-50,654
OPERATING EXPENSES:	'	'	'	'	'
Sales and marketing	192,350	123,604	523,122	787,364	2,041,713
General and administrative	1,346,477	811,283	3,185,185	4,063,904	8,844,169
Depreciation and amortization	81,990	57,170	218,646	168,474	599,257
Total operating expenses	1,620,817	992,057	3,926,953	5,019,742	11,485,139
Loss from operations	-1,539,323	-991,227	-3,837,285	-5,163,668	-11,535,793
Other income (expense):	'	'	'	'	'
Change in fair value of derivative liabilities	66,492	149,793	7,626,121	2,141,178	-990,531
Loss on settlement or modification of debt	'	'	-5,459,582	'	-5,459,582
Interest expense	-151,672	-15,185	-1,577,692	-599,694	-2,870,513
Total other income (expense)	-85,180	134,608	588,847	1,541,484	-9,320,626
NET LOSS	($1,624,503)	($856,619)	($3,248,438)	($3,622,184)	($20,856,419)
Net loss per common share, basic and diluted (in Dollars per share)	($0.01)	($0.01)	($0.02)	($0.03)	'
Weighted average common shares outstanding, basic and diluted (in Shares)	151,019,307	138,431,367	137,142,426	131,461,321	'

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) (USD $)

Consulting Services at $0.231 [Member]

Consulting Services at $0.231 [Member]

Consulting Services at $0.231 [Member]

Consulting Services at $0.155 [Member]

Consulting Services at $0.155 [Member]

Consulting Services at $0.155 [Member]

Legal Services [Member]

Legal Services [Member]

Legal Services [Member]

Preferred Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Accumulated Deficit during Development Stage [Member]

Return 1 [Member]

Return 2 [Member]

Total

Common Stock [Member]

Additional Paid-in Capital [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Return 1 [Member]

Return 2 [Member]

Balance-January 1, 2013 at Dec. 31, 2012

'

'

'

'

'

'

'

'

'

$170

'

'

$12,514

$6,552,878

($17,607,981)

'

'

($11,042,419)

Balance-January 1, 2013 (in Shares) at Dec. 31, 2012

'

'

'

'

'

'

'

'

'

1,700,000

'

'

125,135,113

'

'

'

'

'

Return of shares from Founder

'

'

'

'

'

'

'

'

'

'

-369

-1,289

'

'

'

-369

-1,289

'

Return of shares from Founder (in Shares)

'

'

'

'

'

'

'

'

'

'

-3,686,634

-12,886,346

'

'

'

'

'

'

Conversion of notes payable and accrued interest into common stock at $0.03 per share

'

'

'

'

'

'

'

'

'

'

'

'

2,000

543,764

'

'

'

545,764

Conversion of notes payable and accrued interest into common stock at $0.03 per share (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

20,000,000

'

'

'

'

'

Shares issued to third party as debt discount in connection with notes payable at $0.18 per share

'

'

'

'

'

'

'

'

'

'

'

'

120

229,571

'

'

'

229,691

Shares issued to third party as debt discount in connection with notes payable at $0.18 per share (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

1,200,000

'

'

'

'

'

Shares issued as deferred financing costs in connection with notes payable at $0.172 per share

'

'

'

'

'

'

'

'

'

'

'

'

100

171,900

'

'

'

172,000

Shares issued as deferred financing costs in connection with notes payable at $0.172 per share (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

1,000,000

'

'

'

'

'

Shares issued for services

49

112,451

112,500

19

29,981

30,000

12

17,239

17,251

'

'

'

'

'

'

'

'

'

Shares issued for services (in Shares)

486,401

'

'

192,770

'

'

115,000

'

'

'

'

'

'

'

'

'

'

'

Shares issued to acquire software at $0.15 per share

'

'

'

'

'

'

'

'

'

'

'

'

100

149,900

'

'

'

150,000

Shares issued to acquire software at $0.15 per share (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

1,000,000

'

'

'

'

1,000,000

Stock based compensation

'

'

'

'

'

'

'

'

'

'

'

'

'

425,133

'

'

'

425,133

Vesting of restricted stock at $0.40 per share (prior year accrual of $872,387)

'

'

'

'

'

'

'

'

'

'

'

'

545

1,308,040

'

'

'

1,308,585

Vesting of restricted stock at $0.40 per share (prior year accrual of $872,387) (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

5,452,434

'

'

'

'

'

Reclassification of derivative liabilities to equity

'

'

'

'

'

'

'

'

'

'

'

'

'

6,384,814

'

'

'

6,384,814

Reclassification of warrants as derivative liabilities

'

'

'

'

'

'

'

'

'

'

'

'

'

-2,013,972

'

'

'

-2,013,972

Loss on debt modification of notes payable

'

'

'

'

'

'

'

'

'

'

'

'

'

5,035,609

'

'

'

5,035,609

Net loss

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-3,248,438

'

'

-3,248,438

Balance-September 30, 2013 (in Shares)

'

'

'

'

'

'

'

'

'

750,068

'

'

155,686,534

'

'

'

'

'

Conversion of note payable-Affiliate to equity at $0.15 per share

'

'

'

'

'

'

'

'

'

'

'

'

369

552,994

'

'

'

553,363

Conversion of note payable-Affiliate to equity at $0.15 per share (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

3,686,634

'

'

'

'

'

Beneficial conversion feature associated with notes payable

'

'

'

'

'

'

'

'

'

'

'

'

'

493,115

'

'

'

493,115

Conversion of preferred shares to common shares at $0.0679 per share

'

'

'

'

'

'

'

'

'

-95

'

'

1,399

-1,304

'

'

'

'

Conversion of preferred shares to common shares at $0.0679 per share (in Shares)

'

'

'

'

'

'

'

'

'

-949,932

'

'

13,991,162

'

'

'

'

'

Balance-September 30, 2013 at Sep. 30, 2013

'

'

'

'

'

'

'

'

'

$75

'

'

$15,569

$19,992,113

($20,856,419)

'

'

($848,662)

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) (Parentheticals) (USD $)	9 Months Ended
	Sep. 30, 2013
Conversion of Note Payable - Affiliate to Equity,Per Share	$0.15
Convertible Preferred Stock, Conversion Price	$0.07
Conversion of notes payable and accrued interest into common stock,Per Share	$0.03
Shares issued as to third party debt discount in connection with notes payable,Per Share	$0.18
Shares issued as deferred financing costs in connection with notes payable,Per Share	$0.17
Shares issued to acquire software,Per Share	$0.15
Vesting of restricted shares,Per Share	$0.40
Consulting Services at $0.231 [Member]	'
Shares issued for consulting services,Per Share	$0.23
Consulting Services at $0.155 [Member]	'
Shares issued for consulting services,Per Share	$0.16
Legal Services [Member]	'
Shares issued for legal services,Per Share	$0.15

CONDENSED_CONSOLIDATED_STATEME3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (USD $)	9 Months Ended		49 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES	'	'	'
Net loss	($3,248,438)	($3,622,184)	($20,856,419)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'	'
Depreciation and amortization	218,646	168,474	599,257
Amortization of debt discount	388,682	571,184	1,644,251
Amortization of deferred financing costs	46,579	'	46,579
Change in fair value of derivative liabilities	-7,626,121	-2,141,178	990,531
Loss on modification of warrants	1,027,371	'	1,027,371
Loss on settlement of notes payable	5,459,582	'	5,459,582
Stock based compensation	425,133	3,540,573	4,929,996
Changes in operating assets and liabilities:	'	'	'
Accounts receivable	27,268	7,532	-16,600
Prepaid expenses	-104,973	10,555	-108,025
Accounts payable	187,692	216,017	708,489
Accounts payable-affiliate	'	-162,005	21,958
Accrued liabilities	-129,697	29,859	79,878
Deferred revenue	-10,000	13,004	'
Net cash used in operating activities	-1,869,940	-1,368,170	-5,473,152
CASH FLOWS FROM INVESTING ACTIVITIES	'	'	'
Software development costs	-166,273	-216,317	-1,340,697
Purchase of fixed assets	'	'	-23,781
Net cash used in investing activities	-166,273	-216,317	-1,364,478
CASH FLOWS FROM FINANCING ACTIVITIES	'	'	'
Proceeds from notes payable	2,600,000	300,000	7,030,172
Proceeds from notes payable, affiliate	'	357,707	'
Contributed capital received	'	7,154	'
Fees paid to third party in connection with issuance of notes payable	-62,500	'	-62,500
Proceeds from sale of preferred stock	'	200,000	200,000
Proceeds from sale of common stock	'	400,022	390,043
Net cash provided by financing activities	2,537,500	1,264,883	7,557,715
Net increase (decrease) in cash and cash equivalents	501,287	-319,604	720,085
Cash and cash equivalents at beginning of period	218,798	371,393	'
Cash and cash equivalents at end of period	720,085	51,789	720,085
SUPPLEMENTAL INFORMATION	'	'	'
Cash paid for interest	63,510	'	63,510
Cash paid for income taxes	'	'	'
Non-cash investing and financing activities:	'	'	'
Conversion of notes payable and accounts payable-former affiliate to common stock	532,892	'	954,850
Acquisition of technology in exchange for issuance of stock	150,000	'	150,000
Former affiliate payable converted to note payable	'	344,993	545,958
Conversion of notes payable to common and preferred stock	515,000	'	3,284,214
Conversion of accrued interest on notes payable to common stock	59,579	'	59,579
Fair value of warrants issued in connection with preferred, common stock and notes payable	'	4,766,716	15,889,449
Fair value of conversion option issued in connection with notes payable	'	'	787,192
Reclassification of derivative liability to equity	6,384,814	'	6,384,814
Reclassification of warrants as derivative liability	2,013,972	'	2,013,972
Fair value of warrants issued in settlement of accounts payable	'	'	45,206
Issuance of stockholder subscription receivable	'	($120,000)	'

NATURE_OF_OPERATIONS_AND_BASIS

NATURE OF OPERATIONS AND BASIS OF PRESENTATION	9 Months Ended
	Sep. 30, 2013
Disclosure Text Block [Abstract]	'
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	'
	NOTE 1 – NATURE OF OPERATIONS AND BASIS OF PRESENTATION
	Blue Calypso, Inc. (a development stage company) (the “Company”) is engaged in the development and monetization of technology and intellectual property focused on digital word-of-mouth marketing and advertising. The Company has developed a patented platform which enables brands to leverage customer and employee relationships in order to increase brand loyalty and drive revenue.
	The Company has been presented as a "development stage enterprise.” The Company’s primary activities since inception, have been the design and development of its products, negotiating strategic alliances and other agreements, and raising capital. The Company has not commenced its principal operations, nor has it generated significant revenues from its operations since inception.
	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information. Accordingly, they do not include all of the information and disclosures required by GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the condensed consolidated financial statements of the Company as of September 30, 2013, for the three and nine months ended September 30, 2013 and 2012, and for the period from September 11, 2009 (inception) to September 30, 2013. The results of operations for the three and nine months ended September 30, 2013 are not necessarily indicative of the operating results for the full year ending December 31, 2013.  These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related disclosures of the Company as of December 31, 2012 and for the year then ended, which were filed with the Securities and Exchange Commission on Form 10-K/A on October 9, 2013.

GOING_CONCERN_AND_MANAGEMENTS_

GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	9 Months Ended
	Sep. 30, 2013
Liquidity Going Concern Disclosure [Abstract]	'
Liquidity Going Concern Disclosure [Text Block]	'
	NOTE 2 – GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS
	As of September 30, 2013, the Company had cash and cash equivalents of $720,085 and working capital of $591,393. During the nine months ended September 30, 2013, the Company used net cash in operating activities of approximately $1,870,000.  The Company has not yet generated any significant revenues, and has incurred net losses since inception. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.
	Subsequent to September 30, 2013, the Company raised approximately $1,501,000 in cash proceeds from the sale of common stock.  See Note 11.  The Company believes that its current cash on hand will be sufficient to fund its projected  operating requirements through June 2014.
	The Company's primary source of operating funds since inception has been cash proceeds from the issuance of common shares and preferred shares to its initial investors, proceeds from the issuance of convertible secured debentures and the sale of common stock and debentures in private placements.  The Company intends to raise additional capital through private debt and equity investors, but there can be no assurance that these funds will be available on terms acceptable to the Company, or will be sufficient to enable the Company to fully complete its development activities or sustain operations. If the Company is unable to raise sufficient additional funds, it will have to develop and implement a plan to further extend payables, reduce overhead, or scale back its current business plan until sufficient additional capital is raised to support further operations. There can be no assurance that such a plan will be successful.
	Accordingly, the accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values. The condensed consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
Significant Accounting Policies [Text Block]	'
	NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Principles of Consolidation
	The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.  All significant intercompany accounts and transactions have been eliminated in consolidation.
	Revenue Recognition
	The Company recognizes revenue in accordance with ASC 605 (Accounting Standards Codification)  “Revenue Recognition” when persuasive evidence of an arrangement exists, the fee is fixed or determinable, delivery of the product has occurred or services have been rendered and all obligations have been performed pursuant to the terms of the arrangement and collectability is reasonably assured. Revenue includes fees received from customers for advertising and marketing services provided by us and is recognized as earned when performances of agreed to products, activities and services have been delivered.
	Licensing fees are the result of grants of licenses and settlements reached from legal enforcement of the Company's patent rights. Revenue is recognized when the arrangement with the licensee has been signed and the license has been delivered and made effective, provided license fees are fixed or determinable and collectability is reasonably assured. Revenue from settlements reached on legal enforcement of the Company’s patent rights and the release of the licensee from certain legal claims, is recognized on receipt of the settlement amounts. The Company does not assume future performance obligations in its license arrangements.
	Legal costs incurred in connection with intellectual property and patent enforcement litigation are recognized as cost of revenue. Other legal expenses incurred in the normal course of the Company's business are expensed when incurred as selling, general and administrative expenses.
	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the recoverability and useful lives of long-lived assets, the fair value of the Company’s stock, stock-based compensation, fair values relating to warrant and other derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.
	Reclassifications
	Certain amounts in the prior period condensed consolidated financial statements have been reclassified for comparison purposes to conform to the presentation of the current period condensed consolidated financial statements. These reclassifications had no effect on the previously reported net loss.
	Net Loss per Share
	The Company computes basic net income (loss) per share by dividing net income (loss) per share available to common stockholders by the weighted average number of common shares outstanding for the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the “treasury stock” and/or “if converted” methods as applicable. The computation of basic and diluted loss per share as of September 30, 2013 and 2012 excludes potentially dilutive securities when their inclusion would be anti-dilutive, or if their exercise prices were greater than the average market price of the common stock during the period.
	Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share are as follows:
			September 30,
		September 30,	2012
		2013
	Convertible notes payable	21,461,538	-
	Series A convertible preferred stock	11,045,655	25,036,820
	Options to purchase common stock	14,839,073	9,938,210
	Warrants to purchase common stock	32,495,753	32,008,518
	Restricted stock units	13,456,667	13,456,667
	Totals	93,298,686	80,440,215
	Preferred Stock
	Preferred shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. The Company classifies conditionally redeemable preferred shares, which includes preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control, as temporary equity. At all other times, the Company classifies its preferred shares in stockholders’ deficiency.  As of September 30, 2013, the Company does not have any preferred shares subject to mandatory redemption outstanding.
	Convertible Instruments
	GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP.
	When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. The Company also records, when necessary, deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the preferred shares.
	Common Stock Warrants and Other Derivative Financial Instruments
	The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) provide the Company with a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement) providing that such contracts are indexed to the Company's own stock. The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses classification of its common stock purchase warrants and other free standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.
	The Company’s free standing derivatives consist of warrants to purchase common stock that were issued in connection with its private placement transactions (see Note 4) and embedded conversion options with convertible notes. The Company evaluated these derivatives to assess their proper classification in the condensed consolidated balance sheets as of September 30, 2013 and December 31, 2012 using the applicable classification criteria enumerated under GAAP. The Company determined that certain common stock purchase warrants and the embedded conversion features do not contain fixed settlement provisions.  The exercise price of such warrants is subject to adjustment in the event that the Company subsequently issues equity securities or equity linked securities with exercise prices lower than the exercise price in these warrants. The convertible notes contained a conversion feature such that the Company could not ensure it would have adequate authorized shares to meet all possible conversion demands.
	As such, the Company was required to record the warrants and debt derivative which do not have fixed settlement provisions as liabilities and mark to market all such derivatives to fair value at the end of each reporting period.
	The Company has adopted a sequencing policy that reclassifies contracts (from equity to assets or liabilities) with the most recent inception date first. Thus any available shares are allocated first to contracts with the most recent inception dates.
	Stock-Based Compensation
	The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period.  Stock-based compensation expense is recorded by the Company in the same expense classifications in the condensed consolidated statements of operations, as if such amounts were paid in cash.

FAIR_VALUE_OF_FINANCIAL_INSTRU

FAIR VALUE OF FINANCIAL INSTRUMENTS	9 Months Ended
	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
Fair Value Disclosures [Text Block]	'
	NOTE 4 - FAIR VALUE OF FINANCIAL INSTRUMENTS
	The Company measures the fair value of financial assets and liabilities based on the guidance of ASC 820 “Fair Value Measurements and Disclosures” which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
	ASC 820 describes three levels of inputs that may be used to measure fair value:
	Level 1 — quoted prices in active markets for identical assets or liabilities
	Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable
	Level 3—inputs that are unobservable based on an entity’s own assumptions, as there is little, if any, related market activity. (for example, cash flow modeling inputs based on assumptions)
	Financial liabilities as of September 30, 2013 and December 31, 2012 measured at fair value on a recurring basis are summarized below:
		September 30,		Quoted Prices		Significant		Significant
		2013		in Active		Other		Unobservable
				Markets for		Observable		Inputs
				Identical Assets		Inputs		(Level 3)
				(Level 1)		(Level 2)
	Derivative liabilities	$	6,343	$	--	$	--	$	6,343
		December 31,		Quoted Prices		Significant		Significant
		2012		in Active		Other		Unobservable
				Markets for		Observable		Inputs
				Identical Assets		Inputs		(Level 3)
				(Level 1)		(Level 2)
	Derivative liabilities	$	10,964,006	$	--	$	--	$	10,964,006
	The Company determined that the warrants issued in connection with certain financing transactions and certain conversion options related to convertible notes did not have fixed settlement provisions and are deemed to be derivative financial instruments, since the exercise prices were subject to adjustment based on certain subsequent equity issuances. Accordingly, the Company was required to record such warrants and conversion option as liabilities and mark all such derivatives to fair value each reporting period. Such instruments were classified within Level 3 of the valuation hierarchy.
	The fair value of the warrants and the conversion options was calculated using a binomial lattice formula with the following weighted average assumptions during the three and nine months ended September 30, 2013:
	Dividend Yield	0.00%
	Volatility	81.98% to 85.43%
	Risk-free Interest Rate	0.10% -1.71%
	Term	1.07 – 3.5 years
	The risk-free interest rate is the United States Treasury rate on the measurement date having a term equal to the remaining contractual life of the instrument. The volatility is a measure of the amount by which the Company’s share price has fluctuated or is expected to fluctuate. Since the Company’s common stock has not been publicly traded for a long period of time, an average of the historical volatility of comparative companies was used. The dividend yield is 0% as the Company has not made any dividend payment and has no plans to pay dividends in the foreseeable future.
	Level 3 liabilities are valued using unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the derivative liabilities. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s Chief Financial Officer, who reports to the Chief Executive Officer, determine its valuation policies and procedures.
	The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s Chief Financial Officer and are approved by the Chief Executive Officer.
	Level 3 financial liabilities consist of the  derivative liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate.
	Significant observable and unobservable inputs include stock price, exercise price, annual risk free rate, term, and expected volatility, and are classified within Level 3 of the valuation hierarchy. An increase or decrease in volatility or interest free rate, in isolation, can significantly increase or decrease the fair value of the derivative liabilities. Changes in the values of the derivative liabilities are recorded as a component of other income (expense) on the Company’s condensed consolidated statements of operations.
	The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis for the nine months ended September 30, 2013:
	Balance - Beginning of period	$	10,964,006
	Aggregate fair value of derivative instruments issued		3,053,272
	Transfers out due to the expiration and modification of derivative aspect of financial instrument		-6,384,814
	Change in fair value of derivative liabilities		-7,626,121
	Balance - End of period	$	6,343

INTANGIBLE_ASSETS

INTANGIBLE ASSETS	9 Months Ended
	Sep. 30, 2013
Disclosure Text Block [Abstract]	'
Intangible Assets Disclosure [Text Block]	'
	NOTE 5 – INTANGIBLE ASSETS
	Intangible assets consist of the following:
		September 30,		December 31,
		2013		2012
	Capitalized Software Development Costs	$	1,592,679	$	1,276,406
	Less: Accumulated amortization		-567,067		-352,957
	Net capitalized development costs	$	1,025,612	$	923,449
	During the nine months ended September 30, 2013, the Company issued 1,000,000 shares of its common stock valued at $150,000 to acquire software based on the share price on the date of the transaction.  The Company recorded the fair value of the shares issued as an intangible asset with an estimated useful life of 5 years.
	Amortization expense relating to the capitalized development costs was $79,906 and $54,152 for the three months ended September 30, 2013 and 2012, respectively and $214,110 and $164,906 for the nine months ended September 30, 2013 and 2012, respectively. Amortization for the next five years is estimated to be as follows:
	2013 (remaining)	$	79,199
	2014		319,484
	2015		296,299
	2016		204,648
	2017		92,981
	Thereafter		33,001
	Total	$	1,025,612

NOTES_PAYABLE

NOTES PAYABLE	9 Months Ended
	Sep. 30, 2013
Disclosure Text Block [Abstract]	'
Long-term Debt [Text Block]	'
	NOTE 6 – NOTES PAYABLE
	May 6, 2013 Convertible Debentures
	On May 6, 2013, the Company issued a convertible debenture in exchange for cash proceeds of $2,400,000 (the “May 2013 Debenture”).  The May 2013 Debenture bears interest at a rate of 10% per annum, is due two years from the issuance date and is convertible into shares of the Company’s common stock at the option of the holder at a conversion price of $0.25 per share.  In connection with the May 2013 Debenture, the Company granted the note holder an aggregate of 1,200,000 shares of common stock with a grant date fair value of $254,400.  The aggregate grant date fair value of the common stock was applied to the principal amount of the May 2013 Debenture to determine the debt discount. Accordingly, the Company allocated $229,691 of the proceeds to the relative fair value of the common stock on the grant date and recorded such amount as a debt discount on the date of the transaction.
	During the three and nine months ended September 30, 2013, the Company recognized $28,673 and $45,624 in amortization of the deferred debt discount relating to the May 2013 Debenture, respectively.  In connection with the May 2013 Debenture, the Company incurred fees payable to a third party aggregating $62,500, and issued an aggregate of 1,000,000 shares with a grant date fair value of $172,000 to a third-party.  Such amounts have been recognized as Deferred Financing Costs on the date of the transaction, and are being amortized over the term of the May 2013 Debenture.   During the three and nine months ended September 30, 2013, the Company recognized $29,232 and $46,579 in amortization of the deferred financing costs relating to the May 2013 Debenture, respectively.
	On September 13, 2013, the Company modified certain terms of the May 2013 Debenture in order to induce the holder to convert the May 2013 Debenture into shares of the Company’s common stock as well as to eliminate certain restrictive covenants in the May 2013 Debenture. In exchange, the Company provided for a temporary reduction in the conversion price of the May 2013 Debenture to $0.13 per share through December 31, 2013, after which the conversion price will revert back to the original conversion price of $0.25 per share. In accordance with ASC 470-20, the fair value of the consideration will be measured and recognized as an expense on the date that the inducement offer is accepted by the holder.
	April 12, 2012 Senior Secured Convertible Debentures
	From April 2012 through January 2013, the Company issued senior secured convertible debentures (the “Secured Convertible Debentures”) in exchange for an aggregate cash proceeds of $515,000 ($50,000 of which were received on January 15, 2013). The Secured Convertible Debentures had a stated interest rate of 8% per annum, were due on June 30, 2013 and were originally convertible into shares of the Company’s common stock at the option of the holder at a conversion price of market on the trading day immediately preceding the date of conversion.
	The Company identified an embedded derivative related to a conversion option in the Secured Convertible Debentures. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivative as of the inception date of the Secured Convertible Debentures and to fair value the derivative as of each subsequent reporting date.
	At the inception of the Secured Convertible Debentures, the Company determined the aggregate fair value of of the embedded derivatives to be $122,938.
	On April 29, 2013, the Company modified the Secured Convertible Debentures and accrued interest, in the aggregate amount of $545,958 to a fixed conversion price of $0.03 per share and a maturity date of June 30, 2013.  In connection with the debt modification, the Company recorded a loss on debt modification of $5,459,582 representing the difference between the fair value of the aggregate shares issuable under the new conversion price and the original conversion terms of the Secured Convertible Debenture.
	During the nine months ended September 30, 2013, the holder of the Secured Convertible Debentures converted the aggregate principal amount of $515,000 and accrued interest and fees aggregating $30,764 into 20,000,000 shares of common stock.  Concurrently with this transaction, a shareholder cancelled 12,886,346 shares of his common stock and returned them to the Company.
	November 15, 2012 Unit Offering
	On November 15, 2012, the Company commenced a private offering of up to $3,000,000 of units (the "Units") at a purchase price of $50,000 per unit pursuant to the securities purchase agreement dated November 15, 2012 (the “Purchase Agreement”). Each Unit consists of a 10% Convertible Debenture in the principal amount of $50,000 (the “10% Debenture”) and 12,500 shares of the Company’s common stock. The 10% Debenture bears interest at a rate of 10% per annum, is due two years from the issuance date and is convertible into shares of the Company’s common stock at a conversion price of $0.20 per share. Though December 31, 2012, we issued and sold an aggregate of 9 units totaling $450,000. The 10% Debentures were determined to have an embedded beneficial conversion feature (“BCF”) under the provisions of ASC 470-20, “Debt with Conversion and Other Options” based on the issue date market value and the exercise price of $0.20 per share. In accordance with ASC 470-20, an embedded beneficial conversion feature shall be recognized separately at issuance by allocating a portion of the proceeds equal to the intrinsic value of that feature to additional paid capital. Accordingly, a discount of $225,000 was recorded at issuance. During the nine months ended September 30, 2013 an additional $150,000 of 10% Debentures were issued and a discount of $16,667 was recorded. Amortization expense of $29,632 and $88,896  was recorded during the three and  nine months ended September 30, 2013, respectively. The note balance was $449,748 net of discount of $150,252 at September 30, 2013.

WARRANT_DERIVATIVE_LIABILITIES

WARRANT DERIVATIVE LIABILITIES	9 Months Ended
	Sep. 30, 2013
Warrant Derivative Liability [Abstract]	'
Warrant Derivative Liability [Text Block]	'
	NOTE 7 - WARRANT DERIVATIVE LIABILITIES
	The Company issued warrants in conjunction with the issuance of convertible debentures and the sale of Series A Convertible Preferred and Common Stock.  These warrants contained certain reset provisions. Therefore, in accordance with ASC 815-40,  the Company classified the fair value of the warrant as a liability at the date of issuance.  Subsequent to the initial issuance date, the Company is required to adjust the warrant to fair value as an adjustment to current period operations.
	On April 19, 2013, the reset provisions of an aggregate of 22,091,310 warrants expired. Accordingly, the fair value at the date of expiration of $4,027,945 was reclassified from liabilities to equity.
	On April 29, 2013, in connection with an amendment to the Secured Convertible Debentures, the Company reinstated the reset provisions of an aggregate of 11,045,655 warrants and extended their term from August 31, 2016 to April 30, 2018.  The fair value of the modified warrants of $3,041,343 was recorded as a liability with $2,013,972 reclassified from equity (based on original terms) and $1,027,381 charged to current period interest (based on term modifications). The fair values were determined using the binomial lattice model.
	On September 13, 2013, in connection with an amendment to the Secured Convertible Debentures, the Company modified the terms of 11,045,655 warrants as described above, 2,945,508 warrants issued on March 31, 2012 and 6,500,000 warrants issued on April 12, 2012, reducing the exercise prices from $0.10 per share to $0.05 per share; and eliminating the embedded reset provisions.  Accordingly, the Company determined the change in fair values of $64,017 to current period expense and reclassified the adjusted liability to equity of $2,356,870.  The fair values were determined using the binomial lattice model.
	.

STOCKHOLDERS_DEFICIENCY

STOCKHOLDERS' DEFICIENCY	9 Months Ended
	Sep. 30, 2013
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	NOTE 8 – STOCKHOLDERS’ DEFICIENCY
	Common Stock
	During the nine months ended September 30, 2013, 949,932 shares of the Company’s Series A Convertible Preferred Stock were converted into an aggregate of 13,991,162 shares of common stock at the stated conversion price of $0.0679 per share.
	During the nine months ended September 30, 2013, the Company issued an aggregate of 794,171 shares of common stock to consultants valued at approximately $160,000 for services previously rendered.
	Stock Options
	During the nine months ended September 30, 2013, the Company granted options to purchase an aggregate of 4,578,530 shares of common stock to certain employees and directors. These options vest over a 2 to 3 year period, have a term of 10 years, and contain exercise prices between $0.14 and $0.24 per share. The options had an aggregate grant fair date value of $484,186.
	During the nine months ended September 30, 2013, the Company granted options to purchase an aggregate of 800,000 shares of common stock to certain consultants. These options vest over a 3 year period, have a term of 10 years, and contain an exercise price of $0.24 per share. The options had an aggregate grant date fair value of $84,880.
	Option valuation models require the input of highly subjective assumptions. The fair value of stock-based payment awards was estimated using the Black-Scholes option model with a volatility figure derived from an index of historical stock prices of comparable entities until sufficient data exists to estimate the volatility using the Company’s own historical stock prices. Management determined this assumption to be a more accurate indicator of value. The Company accounts for the expected life of options in accordance with the “simplified” method which enables the use of the simplified method for “plain vanilla” share options as defined in Staff Accounting Bulletin No. 107. The risk-free interest rate was determined from the implied yields of U.S. Treasury zero-coupon bonds with a remaining life consistent with the expected term of the options.  The fair value of stock-based payment awards during the three and nine months ended September 30, 2013 was estimated using the Black-Scholes pricing model with the following assumptions:
	Risk-free interest rate	0	0.64%-1.39%
	Dividend yield		0%
	Stock price volatility		75%-87%
	Expected life		2 years
	In addition, the Company is required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. In estimating the Company’s forfeiture rate, the Company analyzed its historical forfeiture rate, the remaining lives of unvested options, and the number of vested options as a percentage of total options outstanding. If the Company’s actual forfeiture rate is materially different from its estimate, or if the Company reevaluates the forfeiture rate in the future, the stock-based compensation expense could be significantly different from what the Company has recorded in the current period. The Company estimated forfeitures related to option grants at a weighted average annual rate of  0% per year, as the Company does not yet have adequate historical data, for options granted during the three and nine months ended September 30, 2013 and 2012, respectively.
	The stock-based compensation expense related to option grants was $312,666 and $13,872 during the three months ended September 30, 2013 and 2012, respectively and $390,894 and  $2,958,980 during the nine months ended September 30, 2013 and 2012.
	The following table summarizes the stock option activity for the nine months ended September 30, 2013:
		Options		Weighted Average Exercise Price	Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value
	Outstanding, January 1, 2013	9,460,543		$0.25
	Granted	5,378,530		$0.24
	Outstanding, September 30, 2013	14,839,073		$0.24	8.9	$532,634
	Exercisable, September 30, 2013	8,474,992		$0.22	8.5	$490,791
	As of September 30, 2013, stock-based compensation of $614,557 remains unamortized and is expected to be amortized over the weighted average remaining period of 2.5 years.
	Restricted Stock
	The following table summarizes the restricted stock activity for the nine months ended September 30, 2013:
		Restricted shares issued as of December 31, 2012	13,456,667
		Granted during nine months ended September 30, 2013	-
		Forfeited during nine months ended September 30, 2013	-
		Total Restricted Shares Issued at September 30, 2013	13,456,667
		Vested at September 30, 2013	-5,693,052
		Unvested restricted shares as of September 30, 2013	7,763,615
	Stock based compensation expense related to restricted stock grants was $470,436 and $436,194 for the three months ended September 30, 2013 and 2012, respectively; and $1,342,824 and $581,593 the nine months ended September 30, 2013 and 2012, respectively. As of September 30, 2013, the stock-based compensation relating to restricted stock of $2,912,245 remains unamortized and is expected to be amortized over the remaining period of approximately 2 years.

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	NOTE 9 – RELATED PARTY TRANSACTIONS
	Aztec Systems, Inc. (“Aztec”) was an affiliate of the Company that provided administrative and technical support services to the Company.  The majority owner of Aztec was also the majority stockholder of the Company until the sale of Aztec on June 15, 2012.  During the nine months ended September 30, 2013, Aztec converted convertible debentures aggregating $522,891 and accrued interest aggregating approximately $30,000 into 3,686,634  shares of common stock. Concurrently with this issuance a shareholder cancelled 3,686,634shares of his common stock and returned them to the Company. During the nine months ended September 30, 2013, the Company recorded amortization of the debt discount relating to this note aggregating approximately $254,162.

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	NOTE 10 – COMMITMENTS AND CONTINGENCIES
	In the normal course of business the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. Legal fees for such matters are expensed as incurred and we accrue for adverse outcomes as they become probable and estimable.
	On July 31, 2012, the Company filed a patent infringement complaint against Groupon, Inc. (Case No. 6:12-cv-00486) alleging infringement of two of the Company’s patents, Nos. 7,664,516 and 8,155,679, focused on the Company’s peer-to-peer marketing technology.   On August 2, 2013, Groupon, Inc. filed a counterclaim for declaratory judgment of noninfringement and invalidity for all asserted patents. The case is presently in the early stages of discovery.
	On October 17, 2012, the Company filed patent infringement complaints against YELP, Inc. (Case No. 6:12-cv-00788) and IZEA, Inc. (Case No.6:12-cv-00786) The suits allege infringement of two of the Company’s patents, Nos. 7,664,516 and 8,155,679. The complaints were filed in the U.S. District Court in the Eastern District of Texas, Tyler Division.   On August 2, 2013, YELP, Inc. filed a counterclaim for declaratory judgment of noninfringement, invalidity, and unenforceability for all asserted patents. The cases are presently in the early stages of discovery.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2013
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	NOTE 11 – SUBSEQUENT EVENTS
	Management has evaluated subsequent events or transactions occurring through the date on which the condensed consolidated financial statements were issued.
	Subsequent to September 30, 2013, the Company entered into securities purchase agreements with certain investors and sold an aggregate of 11,546,154 shares of common stock at a purchase price of $0.13 per share in consideration of gross proceeds of $1,501,000.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
Consolidation, Policy [Policy Text Block]	'
	Principles of Consolidation
	The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.  All significant intercompany accounts and transactions have been eliminated in consolidation.
Revenue Recognition, Policy [Policy Text Block]	'
	Revenue Recognition
	The Company recognizes revenue in accordance with ASC 605 (Accounting Standards Codification)  “Revenue Recognition” when persuasive evidence of an arrangement exists, the fee is fixed or determinable, delivery of the product has occurred or services have been rendered and all obligations have been performed pursuant to the terms of the arrangement and collectability is reasonably assured. Revenue includes fees received from customers for advertising and marketing services provided by us and is recognized as earned when performances of agreed to products, activities and services have been delivered.
	Licensing fees are the result of grants of licenses and settlements reached from legal enforcement of the Company's patent rights. Revenue is recognized when the arrangement with the licensee has been signed and the license has been delivered and made effective, provided license fees are fixed or determinable and collectability is reasonably assured. Revenue from settlements reached on legal enforcement of the Company’s patent rights and the release of the licensee from certain legal claims, is recognized on receipt of the settlement amounts. The Company does not assume future performance obligations in its license arrangements.
	Legal costs incurred in connection with intellectual property and patent enforcement litigation are recognized as cost of revenue. Other legal expenses incurred in the normal course of the Company's business are expensed when incurred as selling, general and administrative expenses.
Use of Estimates, Policy [Policy Text Block]	'
	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the recoverability and useful lives of long-lived assets, the fair value of the Company’s stock, stock-based compensation, fair values relating to warrant and other derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.
Reclassification, Policy [Policy Text Block]	'
	Reclassifications
	Certain amounts in the prior period condensed consolidated financial statements have been reclassified for comparison purposes to conform to the presentation of the current period condensed consolidated financial statements. These reclassifications had no effect on the previously reported net loss.
Earnings Per Share, Policy [Policy Text Block]	'
	Net Loss per Share
	The Company computes basic net income (loss) per share by dividing net income (loss) per share available to common stockholders by the weighted average number of common shares outstanding for the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the “treasury stock” and/or “if converted” methods as applicable. The computation of basic and diluted loss per share as of September 30, 2013 and 2012 excludes potentially dilutive securities when their inclusion would be anti-dilutive, or if their exercise prices were greater than the average market price of the common stock during the period.
	Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share are as follows:
			September 30,
		September 30,	2012
		2013
	Convertible notes payable	21,461,538	-
	Series A convertible preferred stock	11,045,655	25,036,820
	Options to purchase common stock	14,839,073	9,938,210
	Warrants to purchase common stock	32,495,753	32,008,518
	Restricted stock units	13,456,667	13,456,667
	Totals	93,298,686	80,440,215
Preferred Stock Policy, [Policy Text Block]	'
	Preferred Stock
	Preferred shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. The Company classifies conditionally redeemable preferred shares, which includes preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control, as temporary equity. At all other times, the Company classifies its preferred shares in stockholders’ deficiency.  As of September 30, 2013, the Company does not have any preferred shares subject to mandatory redemption outstanding.
Convertible Instruments Policy, [Policy Text Block]	'
	Convertible Instruments
	GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP.
	When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. The Company also records, when necessary, deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the preferred shares.
Common Stock Warrants And Other Derivative Financial Instrument Policy, [Policy Text Block]	'
	Common Stock Warrants and Other Derivative Financial Instruments
	The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) provide the Company with a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement) providing that such contracts are indexed to the Company's own stock. The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses classification of its common stock purchase warrants and other free standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.
	The Company’s free standing derivatives consist of warrants to purchase common stock that were issued in connection with its private placement transactions (see Note 4) and embedded conversion options with convertible notes. The Company evaluated these derivatives to assess their proper classification in the condensed consolidated balance sheets as of September 30, 2013 and December 31, 2012 using the applicable classification criteria enumerated under GAAP. The Company determined that certain common stock purchase warrants and the embedded conversion features do not contain fixed settlement provisions.  The exercise price of such warrants is subject to adjustment in the event that the Company subsequently issues equity securities or equity linked securities with exercise prices lower than the exercise price in these warrants. The convertible notes contained a conversion feature such that the Company could not ensure it would have adequate authorized shares to meet all possible conversion demands.
	As such, the Company was required to record the warrants and debt derivative which do not have fixed settlement provisions as liabilities and mark to market all such derivatives to fair value at the end of each reporting period.
	The Company has adopted a sequencing policy that reclassifies contracts (from equity to assets or liabilities) with the most recent inception date first. Thus any available shares are allocated first to contracts with the most recent inception dates.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	'
	Stock-Based Compensation
	The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period.  Stock-based compensation expense is recorded by the Company in the same expense classifications in the condensed consolidated statements of operations, as if such amounts were paid in cash.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	'
			September 30,
		September 30,	2012
		2013
	Convertible notes payable	21,461,538	-
	Series A convertible preferred stock	11,045,655	25,036,820
	Options to purchase common stock	14,839,073	9,938,210
	Warrants to purchase common stock	32,495,753	32,008,518
	Restricted stock units	13,456,667	13,456,667
	Totals	93,298,686	80,440,215

FAIR_VALUE_OF_FINANCIAL_INSTRU1

FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)	9 Months Ended
	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'
		September 30,		Quoted Prices		Significant		Significant
		2013		in Active		Other		Unobservable
				Markets for		Observable		Inputs
				Identical Assets		Inputs		(Level 3)
				(Level 1)		(Level 2)
	Derivative liabilities	$	6,343	$	--	$	--	$	6,343
		December 31,		Quoted Prices		Significant		Significant
		2012		in Active		Other		Unobservable
				Markets for		Observable		Inputs
				Identical Assets		Inputs		(Level 3)
				(Level 1)		(Level 2)
	Derivative liabilities	$	10,964,006	$	--	$	--	$	10,964,006
	'
	Dividend Yield	0.00%
	Volatility	81.98% to 85.43%
	Risk-free Interest Rate	0.10% -1.71%
	Term	1.07 – 3.5 years
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	'
	Balance - Beginning of period	$	10,964,006
	Aggregate fair value of derivative instruments issued		3,053,272
	Transfers out due to the expiration and modification of derivative aspect of financial instrument		-6,384,814
	Change in fair value of derivative liabilities		-7,626,121
	Balance - End of period	$	6,343

INTANGIBLE_ASSETS_Tables

INTANGIBLE ASSETS (Tables)	9 Months Ended
	Sep. 30, 2013
Disclosure Text Block [Abstract]	'
Schedule of Finite-Lived Intangible Assets [Table Text Block]	'
		September 30,		December 31,
		2013		2012
	Capitalized Software Development Costs	$	1,592,679	$	1,276,406
	Less: Accumulated amortization		-567,067		-352,957
	Net capitalized development costs	$	1,025,612	$	923,449
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	'
	2013 (remaining)	$	79,199
	2014		319,484
	2015		296,299
	2016		204,648
	2017		92,981
	Thereafter		33,001
	Total	$	1,025,612

STOCKHOLDERS_DEFICIENCY_Tables

STOCKHOLDERS' DEFICIENCY (Tables)	9 Months Ended
	Sep. 30, 2013
Stockholders' Equity Note [Abstract]	'
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	'
	Risk-free interest rate	0	0.64%-1.39%
	Dividend yield		0%
	Stock price volatility		75%-87%
	Expected life		2 years
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
		Options		Weighted Average Exercise Price	Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value
	Outstanding, January 1, 2013	9,460,543		$0.25
	Granted	5,378,530		$0.24
	Outstanding, September 30, 2013	14,839,073		$0.24	8.9	$532,634
	Exercisable, September 30, 2013	8,474,992		$0.22	8.5	$490,791
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]	'
		Restricted shares issued as of December 31, 2012	13,456,667
		Granted during nine months ended September 30, 2013	-
		Forfeited during nine months ended September 30, 2013	-
		Total Restricted Shares Issued at September 30, 2013	13,456,667
		Vested at September 30, 2013	-5,693,052
		Unvested restricted shares as of September 30, 2013	7,763,615

GOING_CONCERN_AND_MANAGEMENTS_1

GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS (Details) (USD $)	9 Months Ended		49 Months Ended				1 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Dec. 31, 2012	Dec. 31, 2011	Sep. 10, 2009	Nov. 08, 2013
							Subsequent Event [Member]
GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS (Details) [Line Items]	'	'	'	'	'	'	'
Cash and Cash Equivalents, at Carrying Value	$720,085	$51,789	$720,085	$218,798	$371,393	'	'
Working Capital	591,393	'	'	'	'	'	'
Net Cash Provided by (Used in) Operating Activities	-1,869,940	-1,368,170	-5,473,152	'	'	'	'
Proceeds from Issuance of Common Stock (in Dollars)	'	$400,022	$390,043	'	'	'	$1,501,000

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Potentially dilutive securities excluded from the computation of basic and diluted net income (loss)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share	93,298,686	80,440,215
Convertible Notes Payable [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share	21,461,538	'
Convertible Debt Securities [Member] | Common Stock [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share	11,045,655	25,036,820
Vested Option [Member] | Common Stock [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share	14,839,073	9,938,210
Warrant [Member] | Common Stock [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share	32,495,753	32,008,518
Restricted Stock Units (RSUs) [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share	13,456,667	13,456,667

FAIR_VALUE_OF_FINANCIAL_INSTRU2

FAIR VALUE OF FINANCIAL INSTRUMENTS (Details)	9 Months Ended
	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
Fair Value Assumptions, Expected Dividend Rate	0.00%

FAIR_VALUE_OF_FINANCIAL_INSTRU3

FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Financial liabilities measured at fair value on a recurring basis (USD $)	Sep. 30, 2013	Dec. 31, 2012
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Financial liabilities measured at fair value on a recurring basis [Line Items]	'	'
Derivative liabilities	$6,343	$10,964,006
Fair Value, Inputs, Level 1 [Member]	'	'
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Financial liabilities measured at fair value on a recurring basis [Line Items]	'	'
Derivative liabilities	'	'
Fair Value, Inputs, Level 2 [Member]	'	'
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Financial liabilities measured at fair value on a recurring basis [Line Items]	'	'
Derivative liabilities	'	'
Fair Value, Inputs, Level 3 [Member]	'	'
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Financial liabilities measured at fair value on a recurring basis [Line Items]	'	'
Derivative liabilities	$6,343	$10,964,006

FAIR_VALUE_OF_FINANCIAL_INSTRU4

FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - The fair value of the warrants and the conversion options	9 Months Ended
	Sep. 30, 2013
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - The fair value of the warrants and the conversion options [Line Items]	'
Dividend Yield	0.00%
Volatility	'81.98% to 85.43%
Risk-free Interest Rate	'0.10% -1.71%
Term	'1.07 - 3.5 years

FAIR_VALUE_OF_FINANCIAL_INSTRU5

FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - The fair value of the warrants and the conversion options (Parentheticals)	9 Months Ended
	Sep. 30, 2013
Minimum [Member]	'
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - The fair value of the warrants and the conversion options (Parentheticals) [Line Items]	'
Fair Value Assumptions, Expected Volatility Rate	81.98%
Fair Value Assumptions, Risk Free Interest Rate	0.10%
Fair Value Assumptions, Expected Term	'1 year 25 days
Maximum [Member]	'
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - The fair value of the warrants and the conversion options (Parentheticals) [Line Items]	'
Fair Value Assumptions, Expected Volatility Rate	85.43%
Fair Value Assumptions, Risk Free Interest Rate	1.71%
Fair Value Assumptions, Expected Term	'3 years 6 months

FAIR_VALUE_OF_FINANCIAL_INSTRU6

FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Summary of the changes in the fair value (USD $)	9 Months Ended
	Sep. 30, 2013
Summary of the changes in the fair value [Abstract]	'
Balance - Beginning of period	$10,964,006
Balance - End of period	6,343
Aggregate fair value of derivative instruments issued	3,053,272
Transfers out due to the expiration and modification of derivative aspect of financial instrument	-6,384,814
Change in fair value of derivative liabilities	($7,626,121)

INTANGIBLE_ASSETS_Details

INTANGIBLE ASSETS (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Disclosure Text Block [Abstract]	'	'	'	'
Stock Issued During Period, Shares, Acquisitions (in Shares)	'	'	1,000,000	'
Stock Issued During Period, Value, Acquisitions	'	'	$150,000	'
Finite-Lived Intangible Asset, Useful Life	'	'	'5 years	'
Amortization of Intangible Assets	$79,906	$54,152	$214,110	$164,906

INTANGIBLE_ASSETS_Details_Inta

INTANGIBLE ASSETS (Details) - Intangible assets components (USD $)	Sep. 30, 2013	Dec. 31, 2012
Intangible assets components [Abstract]	'	'
Capitalized Software Development Costs	$1,592,679	$1,276,406
Less: Accumulated amortization	-567,067	-352,957
Net capitalized development costs	$1,025,612	$923,449

INTANGIBLE_ASSETS_Details_The_

INTANGIBLE ASSETS (Details) - The capitalized development costs amortization (USD $)	Sep. 30, 2013
The capitalized development costs amortization [Abstract]	'
2013 (remaining)	$79,199
2014	319,484
2015	296,299
2016	204,648
2017	92,981
Thereafter	33,001
Total	$1,025,612

NOTES_PAYABLE_Details

NOTES PAYABLE (Details) (USD $)

9 Months Ended

49 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

0 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

6-May-13

Sep. 30, 2013

Sep. 30, 2013

Apr. 29, 2013

Jan. 15, 2013

Apr. 12, 2012

Sep. 30, 2013

Jun. 30, 2013

Nov. 15, 2012

Dec. 31, 2012

Sep. 30, 2013

Sep. 30, 2013

Scenario, Forecast [Member]

May 2013 Debenture [Member]

May 2013 Debenture [Member]

May 2013 Debenture [Member]

Senior Secured Convertible Debentures [Member]

Senior Secured Convertible Debentures [Member]

Senior Secured Convertible Debentures [Member]

Senior Secured Convertible Debentures [Member]

Senior Secured Convertible Debentures [Member]

Purchase Agreement [Member]

Purchase Agreement [Member]

Purchase Agreement [Member]

Purchase Agreement [Member]

May 2013 Debenture [Member]

NOTES PAYABLE (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Issuance of Debt

'

'

'

'

'

$2,400,000

'

'

'

'

'

'

'

'

$450,000

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

10.00%

'

'

'

'

'

8.00%

'

10.00%

'

'

'

Debt Conversion, Converted Instrument, Expiration Period

'

'

'

'

'

'2 years

'

'

'

'

'

'

'

'2 years

'

'

'

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

'

'

'

'

$0.13

$0.25

'

'

'

'

'

'

$0.03

$0.20

'

'

'

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

'

'

'

'

'

1,200,000

'

'

'

'

'

'

'

12,500

'

'

'

Debt Conversion, Converted Instrument, Amount

'

344,993

545,958

'

'

254,400

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Unamortized Discount

'

'

'

225,000

'

229,691

'

'

'

'

'

'

'

'

'

'

'

Amortization of Debt Discount (Premium)

388,682

571,184

1,644,251

'

'

'

28,673

45,624

'

'

'

'

'

'

'

29,632

88,896

Debt Instrument, Fee Amount

'

'

'

'

'

'

62,500

62,500

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Issued for Services (in Shares)

'

'

'

'

'

'

'

1,000,000

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Value, Issued for Services

'

'

'

'

'

'

'

172,000

'

'

'

'

'

'

'

'

'

Amortization of Financing Costs

'

'

'

'

'

'

29,232

46,579

'

'

'

'

'

'

'

'

'

Period of Availability of Reduced Conversion Price

'

'

'

'

'

'

'

31-Dec-13

'

'

'

'

'

'

'

'

'

Proceeds from Convertible Debt

'

'

'

'

'

'

'

'

'

50,000

515,000

'

'

'

'

'

'

Embedded Derivative, Fair Value of Embedded Derivative Liability

'

'

'

'

'

'

'

'

'

'

122,938

'

'

'

'

'

'

Debt Instrument, Increase, Accrued Interest

'

'

'

'

'

'

'

'

545,958

'

'

30,764

'

'

'

'

'

Available-for-sale Debt Securities, Gross Unrealized Loss

'

'

'

'

'

'

'

'

'

'

'

5,459,582

'

'

'

'

'

Debt Instrument, Convertible, Number of Equity Instruments

'

'

'

'

'

'

'

'

'

'

'

20,000,000

'

'

'

'

'

Cancellation of Unissued Common Stock Shares (in Shares)

'

'

'

'

'

'

'

'

'

'

'

12,886,346

'

'

'

'

'

Private Offering Maximum Limit Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

3,000,000

'

'

'

Private Offering Per Unit Cost (in Dollars per Item)

'

'

'

'

'

'

'

'

'

'

'

'

'

50,000

'

'

'

Debt Instrument, Face Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

50,000

'

'

'

Number of Units Sold

'

'

'

'

'

'

'

'

'

'

'

'

'

'

9

'

'

Debt Instrument, Increase (Decrease), Net

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

150,000

Debt Instrument, Unamortized Discount (Premium), Net

150,252

'

150,252

'

'

'

'

'

'

'

'

'

'

'

'

16,667

16,667

Long-term Debt, Gross

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$449,748

$449,748

WARRANT_DERIVATIVE_LIABILITIES1

WARRANT DERIVATIVE LIABILITIES (Details) (USD $)	0 Months Ended				3 Months Ended		9 Months Ended		49 Months Ended
	Apr. 29, 2013	Apr. 19, 2013	Apr. 12, 2012	Mar. 31, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 13, 2013
WARRANT DERIVATIVE LIABILITIES (Details) [Line Items]	'	'	'	'	'	'	'	'	'	'
Class of Warrant or Right, Outstanding (in Shares)	11,045,655	22,091,310	'	'	'	'	'	'	'	'
Equity, Fair Value Adjustment	$2,013,972	$4,027,945	'	'	'	'	'	'	'	'
Fair Value Adjustment of Warrants	3,041,343	'	'	'	'	'	'	'	'	'
Interest Expense, Debt	1,027,381	'	'	'	'	'	'	'	'	'
Fair value of warrants issued in connection with preferred, common stock and notes payable	'	'	6,500,000	2,945,508	'	'	'	4,766,716	15,889,449	'
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Share)	'	'	$0.10	'	'	'	'	'	'	$0.05
Derivative, Gain (Loss) on Derivative, Net	'	'	'	'	66,492	149,793	7,626,121	2,141,178	-990,531	'
Derivative Warrant [Member]	'	'	'	'	'	'	'	'	'	'
WARRANT DERIVATIVE LIABILITIES (Details) [Line Items]	'	'	'	'	'	'	'	'	'	'
Equity, Fair Value Adjustment	'	'	'	'	'	'	2,356,870	'	'	'
Derivative, Gain (Loss) on Derivative, Net	'	'	'	'	'	'	$64,017	'	'	'

STOCKHOLDERS_DEFICIENCY_Detail

STOCKHOLDERS' DEFICIENCY (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
STOCKHOLDERS' DEFICIENCY (Details) [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)	'	'	5,378,530	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	'	'	'8 years 6 months	'
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)	'	'	$0.24	'
Employee Stock Option [Member] | Consultant [Member]	'	'	'	'
STOCKHOLDERS' DEFICIENCY (Details) [Line Items]	'	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award Options Grant Date Intrinsic Value	'	'	$84,880	'
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)	'	'	$0.24	'
Employee Stock Option [Member] | Consultant [Member] | Minimum [Member]	'	'	'	'
STOCKHOLDERS' DEFICIENCY (Details) [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term	'	'	'3 years	'
Employee Stock Option [Member] | Consultant [Member] | Maximum [Member]	'	'	'	'
STOCKHOLDERS' DEFICIENCY (Details) [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term	'	'	'10 years	'
Employee Stock Option [Member] | Employee And Directors [Member]	'	'	'	'
STOCKHOLDERS' DEFICIENCY (Details) [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)	'	'	4,578,530	'
Share Based Compensation Arrangement By Share Based Payment Award Options Grant Date Intrinsic Value	'	'	484,186	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	'	'	'10 years	'
Employee Stock Option [Member] | Employee And Directors [Member] | Minimum [Member]	'	'	'	'
STOCKHOLDERS' DEFICIENCY (Details) [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term	'	'	'2 years	'
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)	'	'	$0.14	'
Employee Stock Option [Member] | Employee And Directors [Member] | Maximum [Member]	'	'	'	'
STOCKHOLDERS' DEFICIENCY (Details) [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term	'	'	'3 years	'
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)	'	'	$0.24	'
Employee Stock Option [Member]	'	'	'	'
STOCKHOLDERS' DEFICIENCY (Details) [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)	'	'	800,000	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Annual Forfeiture Rate	'	'	0.00%	'
Allocated Share-based Compensation Expense	312,666	13,872	390,894	2,958,980
Stock Based Compensation Unamortized	'	'	614,557	'
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	'	'	'2 years 6 months	'
Restricted Stock Units (RSUs) [Member]	'	'	'	'
STOCKHOLDERS' DEFICIENCY (Details) [Line Items]	'	'	'	'
Allocated Share-based Compensation Expense	470,436	436,194	1,342,824	581,593
Stock Based Compensation Unamortized	'	'	'	2,912,245
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	'	'	'	'2 years
Common Stock [Member] | Consultant [Member]	'	'	'	'
STOCKHOLDERS' DEFICIENCY (Details) [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)	'	'	794,171	'
Common Stock [Member]	'	'	'	'
STOCKHOLDERS' DEFICIENCY (Details) [Line Items]	'	'	'	'
Stock Issued During Period, Shares, New Issues (in Shares)	'	'	13,991,162	'
Debt Instrument, Convertible, Conversion Price (in Dollars per share)	$0.07	'	$0.07	'
Share Based Compensation Arrangement By Share Based Payment Award Options Grant Date Intrinsic Value	'	'	$160,000	'
Series A Preferred Stock [Member]	'	'	'	'
STOCKHOLDERS' DEFICIENCY (Details) [Line Items]	'	'	'	'
Convertible Preferred Stock, Shares Issued upon Conversion (in Shares)	949,932	'	949,932	'

STOCKHOLDERS_DEFICIENCY_Detail1

STOCKHOLDERS' DEFICIENCY (Details) - The fair value of stock-based payment awards	9 Months Ended
	Sep. 30, 2013
STOCKHOLDERS' DEFICIENCY (Details) - The fair value of stock-based payment awards [Line Items]	'
Dividend yield	0.00%
Employee Stock Option [Member]	'
STOCKHOLDERS' DEFICIENCY (Details) - The fair value of stock-based payment awards [Line Items]	'
Risk-free interest rate	'0.64%-1.39%
Dividend yield	0.00%
Stock price volatility	'75%-87%
Expected life	'2 years

STOCKHOLDERS_DEFICIENCY_Detail2

STOCKHOLDERS' DEFICIENCY (Details) - The fair value of stock-based payment awards (Parentheticals) (Employee Stock Option [Member])	9 Months Ended
	Sep. 30, 2013
Employee Stock Option [Member]	'
STOCKHOLDERS' DEFICIENCY (Details) - The fair value of stock-based payment awards (Parentheticals) [Line Items]	'
Risk-free interest rate, Minimum	0.64%
Risk-free interest rate, Maximum	1.39%
Stock price volatility, Minimum	75.00%
Stock price volatility, Maximum	87.00%

STOCKHOLDERS_DEFICIENCY_Detail3

STOCKHOLDERS' DEFICIENCY (Details) - The following table summarizes the stock option activity (USD $)	9 Months Ended
	Sep. 30, 2013
The following table summarizes the stock option activity [Abstract]	'
Outstanding, January 1, 2013	9,460,543
Outstanding, January 1, 2013 (in Dollars per share)	$0.25
Granted	5,378,530
Granted (in Dollars per share)	$0.24
Outstanding, September 30, 2013	14,839,073
Outstanding, September 30, 2013 (in Dollars per share)	$0.24
Outstanding, September 30, 2013	'8 years 328 days
Outstanding, September 30, 2013 (in Dollars)	$532,634
Exercisable, September 30, 2013	8,474,992
Exercisable, September 30, 2013 (in Dollars per share)	$0.22
Exercisable, September 30, 2013	'8 years 6 months
Exercisable, September 30, 2013 (in Dollars)	$490,791

STOCKHOLDERS_DEFICIENCY_Detail4

STOCKHOLDERS' DEFICIENCY (Details) - The following table summarizes the restricted stock activity	9 Months Ended
	Sep. 30, 2013
The following table summarizes the restricted stock activity [Abstract]	'
Restricted shares issued as of December 31, 2012	13,456,667
Granted during nine months ended September 30, 2013	'
Forfeited during nine months ended September 30, 2013	'
Total Restricted Shares Issued at September 30, 2013	13,456,667
Vested at September 30, 2013	-5,693,052
Unvested restricted shares as of September 30, 2013	7,763,615

RELATED_PARTY_TRANSACTIONS_Det

RELATED PARTY TRANSACTIONS (Details) (USD $)	9 Months Ended		49 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
RELATED PARTY TRANSACTIONS (Details) [Line Items]	'	'	'
Debt Conversion, Original Debt, Amount	$515,000	'	$3,284,214
Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation (in Shares)	3,686,634	'	'
Amortization of Debt Discount (Premium)	388,682	571,184	1,644,251
Aztec [Member]	'	'	'
RELATED PARTY TRANSACTIONS (Details) [Line Items]	'	'	'
Debt Conversion, Original Debt, Amount	522,891	'	'
Debt Instrument, Increase, Accrued Interest	30,000	'	'
Conversion of Stock, Shares Issued (in Shares)	3,686,634	'	'
Amortization of Debt Discount (Premium)	$254,162	'	'

SUBSEQUENT_EVENTS_Details

SUBSEQUENT EVENTS (Details) (USD $)	9 Months Ended		49 Months Ended	1 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Nov. 08, 2013	Nov. 08, 2013	Sep. 30, 2013
				Subsequent Event [Member]	Subsequent Event [Member]	Common Stock [Member]
				Common Stock [Member]
SUBSEQUENT EVENTS (Details) [Line Items]	'	'	'	'	'	'
Stock Issued During Period, Shares, New Issues	'	'	'	11,546,154	'	13,991,162
Share Price (in Dollars per share)	'	'	'	$0.13	'	'
Proceeds from Issuance of Common Stock (in Dollars)	'	$400,022	$390,043	'	$1,501,000	'